Clinical Trials
3 trialsNCT05219500 2026-04-03
TATCIST
Fusion Pharmaceuticals Inc.
Phase 2 Active not recruiting
NCT06830850 2026-01-15
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Atridia Pty Ltd.
Phase 1 Recruiting
NCT02975934 2025-07-25
TRITON3
pharmaand GmbH
Phase 3 Completed